greeksoup/ stock research

Clorox (CLX) FY2023 results: revenue $7.4 billion, up 4.0% on the year

Clorox Co. (CLX) reported revenue of $7.4 billion for fiscal 2023, the year ended 30 June 2023, up 4.0% on the year before. Net income was $149 million, down 67.7%, and diluted earnings per share $1.20. The figures are the company's own, from the 10-K it filed with the SEC on 10 August 2023.

Revenue
$7.4 billion
+4.0% on the year
FY2016FY2023
Operating margin
n/a
FY2016FY2023
Net income
$149 million
-67.7% on the year
FY2016FY2023
Diluted EPS
$1.20
-67.8% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue7,3897,1077,341+4.0%
Cost of revenue4,4814,5624,142-1.8%
Gross profit2,9082,5453,199+14.3%
Gross margin39.4%35.8%43.6%
Research and development138132149+4.5%
Selling, general and administrative1,1839541,004+24.0%
Interest expense90.010699.0-15.1%
Pre-tax income238607900-60.8%
Income tax77.0136181-43.4%
Effective tax rate32.4%22.4%20.1%
Net income149462710-67.7%
Net margin2.0%6.5%9.7%
Diluted EPS$1.20$3.73$5.58-67.8%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow1,1587861,276+47.3%
Capital expenditure228251331-9.2%
Free cash flow930535945+73.8%
Free cash flow margin12.6%7.5%12.9%
Cash from investing-223-229-452
Cash from financing-753-689-1,391
Depreciation and amortisation236224211+5.4%
Share-based compensation73.052.050.0+40.4%
Buybacks0.025.0905
Dividends paid583571558+2.1%
Dividend per share$4.72$3.48$4.49+35.6%
Diluted shares, weighted124m124m127m+0.2%
Shares outstanding at period end124m123m123m+0.5%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity220556411-60.4%
Non-controlling interest168173181-2.9%
Debt2,5272,7112,784-6.8%
Operating lease liabilities310314301-1.3%
Finance lease liabilities21.013.015.0+61.5%
Other liabilities2,6992,3912,642+12.9%
Total liabilities and equity5,9456,1586,334-3.5%
Fixed assets1,3451,3341,302+0.8%
Goodwill1,2521,5581,575-19.6%
Intangible assets712884918-19.5%
Cash and equivalents367183319+100.5%
Receivables688681604+1.0%
Inventory696755752-7.8%
Other assets885763864+16.0%
Total assets5,9456,1586,334-3.5%

10-K for the year ended 30 June 2023, filed 10 August 2023: the filing.